NCT00288223

Telithromycin in Acute Exacerbation of Chronic Bronchitis

Multicenter Non Comparative Phase IV Study on the Safety and Efficacy of Telithromycin 800 mg Per Day for 5 Days in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adults

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: Sanofi · Industry
• Sex: All
• Age: 35 Years
• Healthy volunteers: Not accepted

Summary

Study objectives: * to document the clinical efficacy of telithromycin(800 mg per day for 5 days) at Test Of the Cure (TOC)visit (D12-D19), in acute exacerbation of chronic bronchitis. * to assess the long-term clinical efficacy of telithromycin by telephone at D25-D35 (V3) * to assess the safety of telithromycin

Conditions

• Bronchitis, Chronic

Interventions

Type	Name	Description
DRUG	Telithromycin	one daily intake of 800 mg (i.e. 2 x 400 mg tablets) per os in a single intake with a meal for 5 days.

Timeline

• Start date: 2006-01-01
• Primary completion: 2007-01-01
• Completion: 2007-01-01
• First posted: 2006-02-07
• Last updated: 2009-12-09

Locations

1 site across 1 country: Turkey (Türkiye)